Cardiac 18F-dopamine positron emission tomography predicts the type of phenoconversion of pure autonomic failure
- PMID: 37843677
- DOI: 10.1007/s10286-023-00987-1
Cardiac 18F-dopamine positron emission tomography predicts the type of phenoconversion of pure autonomic failure
Abstract
Purpose: Pure autonomic failure (PAF) is a rare disease characterized by neurogenic orthostatic hypotension (nOH), no known secondary cause, and lack of a neurodegenerative movement or cognitive disorder. Clinically diagnosed PAF can evolve ("phenoconvert") to a central Lewy body disease [LBD, e.g., Parkinson's disease (PD) or dementia with Lewy bodies (DLB)] or to the non-LBD synucleinopathy multiple system atrophy (MSA). Since cardiac 18F-dopamine-derived radioactivity usually is low in LBDs and usually is normal in MSA, we hypothesized that patients with PAF with low cardiac 18F-dopamine-derived radioactivity would be more likely to phenoconvert to a central LBD than to MSA.
Methods: We reviewed data from all the patients seen at the National Institutes of Health Clinical Center from 1994 to 2023 with a clinical diagnosis of PAF and data about 18F-dopamine positron emission tomography (PET).
Results: Nineteen patients (15 with low 18F-dopamine-derived radioactivity, 4 with normal radioactivity) met the above criteria and had follow-up data. Nine (47%) phenoconverted to a central synucleinopathy over a mean of 6.6 years (range 1.5-18.8 years). All 6 patients with low cardiac 18F-dopamine-derived radioactivity who phenoconverted during follow-up developed a central LBD, whereas none of 4 patients with consistently normal 18F-dopamine PET phenoconverted to a central LBD (p = 0.0048), 3 evolving to probable MSA and 1 upon autopsy having neither a LBD nor MSA.
Conclusion: Cardiac 18F-dopamine PET can predict the type of phenoconversion of PAF. This capability could refine eligibility criteria for entry into disease-modification trials aimed at preventing evolution of PAF to symptomatic central LBDs.
Keywords: Dementia with Lewy bodies; Fluorodopamine; Multiple system atrophy; Parkinson’s disease; Pure autonomic failure.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Update of
-
Cardiac 18F-Dopamine Positron Emission Tomography Predicts the Type of Phenoconversion of Pure Autonomic Failure.Res Sq [Preprint]. 2023 Jul 17:rs.3.rs-3157807. doi: 10.21203/rs.3.rs-3157807/v1. Res Sq. 2023. Update in: Clin Auton Res. 2023 Dec;33(6):737-747. doi: 10.1007/s10286-023-00987-1. PMID: 37503103 Free PMC article. Updated. Preprint.
Similar articles
-
Cardiac 18F-Dopamine Positron Emission Tomography Predicts the Type of Phenoconversion of Pure Autonomic Failure.Res Sq [Preprint]. 2023 Jul 17:rs.3.rs-3157807. doi: 10.21203/rs.3.rs-3157807/v1. Res Sq. 2023. Update in: Clin Auton Res. 2023 Dec;33(6):737-747. doi: 10.1007/s10286-023-00987-1. PMID: 37503103 Free PMC article. Updated. Preprint.
-
Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin-Sensitive Magnetic Resonance Imaging and 18F-Fluorodopa-Positron Emission Tomography.Mov Disord. 2025 Apr;40(4):716-726. doi: 10.1002/mds.30119. Epub 2025 Jan 18. Mov Disord. 2025. PMID: 39825743 Free PMC article.
-
Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.Clin Auton Res. 2021 Dec;31(6):677-684. doi: 10.1007/s10286-021-00829-y. Epub 2021 Oct 20. Clin Auton Res. 2021. PMID: 34669076 Free PMC article. Review.
-
Long-term trends in myocardial sympathetic innervation and function in synucleinopathies.Parkinsonism Relat Disord. 2019 Oct;67:27-33. doi: 10.1016/j.parkreldis.2019.09.014. Epub 2019 Sep 16. Parkinsonism Relat Disord. 2019. PMID: 31621602 Free PMC article.
-
An overview on pure autonomic failure.Rev Neurol (Paris). 2024 Jan-Feb;180(1-2):94-100. doi: 10.1016/j.neurol.2023.11.003. Epub 2023 Dec 20. Rev Neurol (Paris). 2024. PMID: 38129276 Review.
Cited by
-
Novel F-18-labeled Tracers of Sympathetic Function for Improved Risk Stratification and Clinical Outcomes.Curr Cardiol Rep. 2025 Feb 26;27(1):61. doi: 10.1007/s11886-025-02197-9. Curr Cardiol Rep. 2025. PMID: 40009333 Review.
-
Neuroimaging in multiple system atrophy: clinical implications and novel developments.J Neural Transm (Vienna). 2025 Apr 11. doi: 10.1007/s00702-025-02921-3. Online ahead of print. J Neural Transm (Vienna). 2025. PMID: 40214765 Review.
-
Extra-cranial cholinergic lesions in dementia with Lewy bodies.Brain. 2024 Jan 4;147(1):10-11. doi: 10.1093/brain/awad408. Brain. 2024. PMID: 38066668 Free PMC article.
-
The phenotype of "pure" autonomic failure.Clin Auton Res. 2025 Jun;35(3):477-485. doi: 10.1007/s10286-025-01121-z. Epub 2025 Mar 7. Clin Auton Res. 2025. PMID: 40053259
-
A pathophysiological biomarker combination separates Lewy body from non-Lewy body neurogenic orthostatic hypotension .Clin Auton Res. 2024 Jun;34(3):329-339. doi: 10.1007/s10286-024-01035-2. Epub 2024 Jun 7. Clin Auton Res. 2024. PMID: 38844644
References
-
- Bradbury S, Eggleston C (1925) Postural hypotension: a report of three cases. Am Heart J 1:73–86 - DOI
-
- Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, Walton RL, Ahmed S, Viollet C, Ding J, Makarious MB, Diez-Fairen M, Portley MK, Shah Z, Abramzon Y, Hernandez DG, Blauwendraat C, Stone DJ, Eicher J, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, St George-Hyslop P, Londos E, Morgan K, Lashley T, Warner TT, Jaunmuktane Z, Galasko D, Santana I, Tienari PJ, Myllykangas L, Oinas M, Cairns NJ, Morris JC, Halliday GM, Van Deerlin VM, Trojanowski JQ, Grassano M, Calvo A, Mora G, Canosa A, Floris G, Bohannan RC, Brett F, Gan-Or Z, Geiger JT, Moore A, May P, Kruger R, Goldstein DS, Lopez G, Tayebi N, Sidransky E, American Genome C, Norcliffe-Kaufmann L, Palma JA, Kaufmann H, Shakkottai VG, Perkins M, Newell KL, Gasser T, Schulte C, Landi F, Salvi E, Cusi D, Masliah E, Kim RC, Caraway CA, Monuki ES, Brunetti M, Dawson TM, Rosenthal LS, Albert MS, Pletnikova O, Troncoso JC, Flanagan ME, Mao Q, Bigio EH, Rodriguez-Rodriguez E, Infante J, Lage C, Gonzalez-Aramburu I, Sanchez-Juan P, Ghetti B, Keith J, Black SE, Masellis M, Rogaeva E, Duyckaerts C, Brice A, Lesage S, Xiromerisiou G, Barrett MJ, Tilley BS, Gentleman S, Logroscino G et al (2021) Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet 53:294–303 - PubMed - PMC - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous